Cargando…

Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period

PURPOSE: To compare the outcomes (stone free rate and complications) of renal stone treatment with and without the use of ureteral access sheath (UAS). The worldwide use of UAS has risen over the last decade; however, questions still remain on the safety and outcomes with its use. We wanted to look...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Ashleigh, Reeves, Thomas, Geraghty, Robert, Pietropaolo, Amelia, Whitehurst, Lily, Somani, Bhaskar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190582/
https://www.ncbi.nlm.nih.gov/pubmed/31342247
http://dx.doi.org/10.1007/s00345-019-02878-5
_version_ 1783527711306678272
author Lima, Ashleigh
Reeves, Thomas
Geraghty, Robert
Pietropaolo, Amelia
Whitehurst, Lily
Somani, Bhaskar K.
author_facet Lima, Ashleigh
Reeves, Thomas
Geraghty, Robert
Pietropaolo, Amelia
Whitehurst, Lily
Somani, Bhaskar K.
author_sort Lima, Ashleigh
collection PubMed
description PURPOSE: To compare the outcomes (stone free rate and complications) of renal stone treatment with and without the use of ureteral access sheath (UAS). The worldwide use of UAS has risen over the last decade; however, questions still remain on the safety and outcomes with its use. We wanted to look at the role of UAS for treatment of consecutive renal stones over a 7-year period. METHODS: The outcomes of flexible ureteroscopy and stone treatment (FURS) for renal stones with and without the use of UAS was prospectively compared from March 2012 to July 2018. Patients were divided into two groups: group-1 where UAS was used for stone treatment and group-2 where a UAS was not used. Data were collected prospectively on consecutive patients for demographics, stone size, location and number, pre and post-operative stent usage, operative time duration, stone free rate (SFR), length of stay and complications. RESULTS: During the study period, 338 patients underwent FURS for renal stones, of which a UAS was used for 203 (60%) patients. The mean age of patients was 56 years (range 2–89 years) with a male:female ratio of 204:134. The mean cumulative stone size and the mean number of stones was 16.5 ± 10.8 mm and 11.37 ± 8.08 mm (P < 0.001), and 2.17 ± 1.99 and 1.66 ± 1.50 (P = 0.009) for groups 1 and 2 respectively. The pre and post-operative stent insertion rates were similar in the two groups. The procedural time was longer in group-1 (54.8 ± 25.8 min) compared to group-2 (41.3 ± 22.2 min) (P < 0.001). The SFR for group-1 (88%) was slightly lower than group-2 (94%) although this was not statistically significant (P = 0.07). There were no intra-operative complications in either of the groups. Post-operative complications were seen in eight patients in group-1 (7 Clavien I/II and 1 Clavien IVa) and two patients in group-2 (Clavien I) (P = 0.19). CONCLUSION: The use of UAS for renal stones is safe with no intra-operative complications noted in our series. Good stone-free rates were obtained for large and multiple renal stones with a small risk of minor complications post-operatively.
format Online
Article
Text
id pubmed-7190582
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71905822020-05-04 Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period Lima, Ashleigh Reeves, Thomas Geraghty, Robert Pietropaolo, Amelia Whitehurst, Lily Somani, Bhaskar K. World J Urol Original Article PURPOSE: To compare the outcomes (stone free rate and complications) of renal stone treatment with and without the use of ureteral access sheath (UAS). The worldwide use of UAS has risen over the last decade; however, questions still remain on the safety and outcomes with its use. We wanted to look at the role of UAS for treatment of consecutive renal stones over a 7-year period. METHODS: The outcomes of flexible ureteroscopy and stone treatment (FURS) for renal stones with and without the use of UAS was prospectively compared from March 2012 to July 2018. Patients were divided into two groups: group-1 where UAS was used for stone treatment and group-2 where a UAS was not used. Data were collected prospectively on consecutive patients for demographics, stone size, location and number, pre and post-operative stent usage, operative time duration, stone free rate (SFR), length of stay and complications. RESULTS: During the study period, 338 patients underwent FURS for renal stones, of which a UAS was used for 203 (60%) patients. The mean age of patients was 56 years (range 2–89 years) with a male:female ratio of 204:134. The mean cumulative stone size and the mean number of stones was 16.5 ± 10.8 mm and 11.37 ± 8.08 mm (P < 0.001), and 2.17 ± 1.99 and 1.66 ± 1.50 (P = 0.009) for groups 1 and 2 respectively. The pre and post-operative stent insertion rates were similar in the two groups. The procedural time was longer in group-1 (54.8 ± 25.8 min) compared to group-2 (41.3 ± 22.2 min) (P < 0.001). The SFR for group-1 (88%) was slightly lower than group-2 (94%) although this was not statistically significant (P = 0.07). There were no intra-operative complications in either of the groups. Post-operative complications were seen in eight patients in group-1 (7 Clavien I/II and 1 Clavien IVa) and two patients in group-2 (Clavien I) (P = 0.19). CONCLUSION: The use of UAS for renal stones is safe with no intra-operative complications noted in our series. Good stone-free rates were obtained for large and multiple renal stones with a small risk of minor complications post-operatively. Springer Berlin Heidelberg 2019-07-24 2020 /pmc/articles/PMC7190582/ /pubmed/31342247 http://dx.doi.org/10.1007/s00345-019-02878-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Lima, Ashleigh
Reeves, Thomas
Geraghty, Robert
Pietropaolo, Amelia
Whitehurst, Lily
Somani, Bhaskar K.
Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period
title Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period
title_full Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period
title_fullStr Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period
title_full_unstemmed Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period
title_short Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period
title_sort impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190582/
https://www.ncbi.nlm.nih.gov/pubmed/31342247
http://dx.doi.org/10.1007/s00345-019-02878-5
work_keys_str_mv AT limaashleigh impactofureteralaccesssheathonrenalstonetreatmentprospectivecomparativenonrandomisedoutcomesovera7yearperiod
AT reevesthomas impactofureteralaccesssheathonrenalstonetreatmentprospectivecomparativenonrandomisedoutcomesovera7yearperiod
AT geraghtyrobert impactofureteralaccesssheathonrenalstonetreatmentprospectivecomparativenonrandomisedoutcomesovera7yearperiod
AT pietropaoloamelia impactofureteralaccesssheathonrenalstonetreatmentprospectivecomparativenonrandomisedoutcomesovera7yearperiod
AT whitehurstlily impactofureteralaccesssheathonrenalstonetreatmentprospectivecomparativenonrandomisedoutcomesovera7yearperiod
AT somanibhaskark impactofureteralaccesssheathonrenalstonetreatmentprospectivecomparativenonrandomisedoutcomesovera7yearperiod